Matnerve Injection contains Methylcobalamin 1500 mcg, a biologically active form of vitamin B12 essential for neurological function and hematopoiesis. It is indicated for the treatment of vitamin B12 deficiency, which may manifest as peripheral neuropathy, megaloblastic anemia, or other neurological disorders. Methylcobalamin plays a critical role in the synthesis of myelin sheath and nerve regeneration, thereby improving nerve conduction and reducing symptoms such as numbness, tingling, and burning sensations. Matnerve Injection is commonly used in conditions like diabetic neuropathy, alcoholic neuropathy, and other peripheral nerve disorders. It may also be employed as an adjunct therapy in cases of spinal cord diseases and certain anemias caused by vitamin B12 deficiency. The injection is administered intramuscularly or intravenously, allowing rapid absorption and prompt therapeutic effects. Dosage and duration of treatment should be determined by a healthcare professional based on the patient’s clinical condition and response. Adverse effects are rare but may include mild allergic reactions or injection site discomfort. Matnerve Injection should be used with caution in patients with hypersensitivity to cobalamin or any component of the formulation. Regular monitoring of vitamin B12 levels and clinical symptoms is recommended to ensure optimal therapeutic outcomes.